# Bone in CKD Alkali Response (BICARb Pilot Trial)

> **NCT05918029** · PHASE2,PHASE3 · RECRUITING · sponsor: **Albert Einstein College of Medicine** · enrollment: 103 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Bone Loss

## Interventions

- **DRUG:** Potassium Citrate Extended Release Oral Tablet
- **OTHER:** Placebo
- **DRUG:** Potassium Citrate and Citric Acid Oral Solution

## Key facts

- **NCT ID:** NCT05918029
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-15
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05918029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05918029, "Bone in CKD Alkali Response (BICARb Pilot Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05918029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*